In vitro fertilisation with recombinant follicle stimulating hormone requires less IU usage compared with highly purified human menopausal gonadotrophin: results from a European retrospective observational chart review

• Main Authors: Blackmore Stuart (Author), Gillard Samantha (Author), Brown Adam P (Author), Trew Geoffrey H (Author), Clewlow Christine (Author), O'Donohoe Paul (Author), Wasiak Radoslaw (Author)
• Format: Book
• Published: BMC, 2010-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

<p>Abstract</p> <p>Background</p> <p>Previous studies have reported conflicting results for the comparative doses of recombinant follicle stimulating hormone (rFSH) and highly purified human menopausal gonadotrophin (hMG-HP) required per cycle of <it>in vitro <...